255
Views
10
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Safety profile of iloperidone in the treatment of schizophrenia

, MD MPH & , MD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Christoffer Polcwiartek, Kristian Kragholm, Ole Schjerning, Claus Graff & Jimmi Nielsen. (2016) Cardiovascular safety of antipsychotics: a clinical overview. Expert Opinion on Drug Safety 15:5, pages 679-688.
Read now
Leslie Citrome, Anna Eramo, Clement Francois, Ruth Duffy, Susan N Legacy, Steve J Offord, Holly B Krasa, Stephen S Johnston, Alice Guiraud-Diawara, Siddhesh A Kamat & Patricia Rohman. (2015) Lack of tolerable treatment options for patients with schizophrenia. Neuropsychiatric Disease and Treatment 11, pages 3095-3104.
Read now

Articles from other publishers (8)

Stephen M. Stahl. 2021. Prescriber's Guide. Prescriber's Guide 359 366 .
Stephen M. Stahl. 2021. Prescriber's Guide. Prescriber's Guide.
S.M. Yasir Arafat. (2020) Iloperidone-induced urinary incontinence in a female patient with schizophrenia: A case report. Neurology, Psychiatry and Brain Research 36, pages 86-87.
Crossref
Shrikant V. Joshi, Ekta P. Patel, Bhavin A. Vyas, Sandesh R. Lodha & Gajanan G. Kalyankar. (2020) Repurposing of Iloperidone: Antihypertensive and ocular hypotensive activity in animals. European Journal of Pharmaceutical Sciences 143, pages 105173.
Crossref
Piotr Stępnicki, Magda Kondej & Agnieszka A. Kaczor. (2018) Current Concepts and Treatments of Schizophrenia. Molecules 23:8, pages 2087.
Crossref
James B. Lohr, Carolyn A. Eidt, Areej Abdulrazzaq Alfaraj & Mounir A. Soliman. (2015) The clinical challenges of akathisia. CNS Spectrums 20:S1, pages 1-16.
Crossref
Drew S. Kern & Anthony E. Lang. 2015. Medication-Induced Movement Disorders. Medication-Induced Movement Disorders 3 19 .
P. Chue & G. Baker. 2015. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 63 83 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.